References
- Friedrichs E. On the pill. Nat Med 2010;16:506–8.
- Lal J. Clinical pharmacokinetics and interaction of centchroman—a mini review. Contraception 2010;81: 275–80.
- Kamboj V, Ray S, Dhawan B. Centchroman. Drugs Today 1992;28:227–32.
- Tejwani PL, Nerkar H, Dhar A, et al. Regression of fibroadenomas with centchroman: a randomized controlled trial. Indian J Surg 2013:1–6.
- Kumar V, Lal J, Singh MM, Gupta RC. Effect of concurrently coadministered drugs on the pharmacokinetic/pharmacodynamic profile of centchroman, a nonsteroidal oral contraceptive, in rats. Contraception 2006;74: 165–73.
- Khurana M, Lal J, Singh MM, et al. Evaluation of interaction potential of certain concurrently administered drugs with pharmacological and pharmacokinetic profile of centchroman in rats. Contraception 2002;66: 47–56.
- Ghosh R, Kamboj VP, Singh MM. Interaction with anti-implantation and estrogen antagonistic activities of dl-ormeloxifene, a selective estrogen receptor modulator, by tetracycline in female Sprague-Dawley rats. Contraception 2001;64:261–9.
- Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006;38:90–6.
- Product information Lipitor® (atorvastatin calcium), 2013. Accessed 1 January 2015 from: www.pfizer.com.au/sites/g/files/g10005016/f/201311/PI_Lipitor_355.pdf
- Simonson SG, Martin PD, Warwick MJ, et al. The effect of rosuvastatin on oestrogen & progestin pharmacokinetics in healthy women taking an oral contraceptive. Br J Clin Pharmacol 2004;57:279–86.
- Steinkellner A, Chen W, Denison SE. Adherence to oral contraception in women on Category X medications. Am J Med 2010;123:929–34.e1.
- Edison RJ, Muenke M. Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins. Am J Med Gen A 2004;131:287–98.
- Lal J, Sharma N. Simultaneous quantification of centchroman and its 7‐demethylated metabolite in rat dried blood spot samples using LC‐MS/MS. Biomed Chromatogr 2012;26:1089–95.
- Neuvonen PJ, Niemi M, Backman JT. Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. Clin Pharmacol Ther 2006;80:565–81.